Health

New research points to critical role of public funding in drug discoveries and development for the last decade

Increased financialization is driving healthcare costs and must be addressed in our nation’s public policy.

How Investor-owned Physician Practices Are Driving up Healthcare Costs

There is not one opioid crisis in America—there are many. And supply-focused measures won’t stop them.

Stigmatizing and relegating an activity to the shadows doesn’t improve anyone’s welfare

Pharmaceutical pushers like Purdue “couldn’t have done their dirty work” without America’s increasingly unbalanced economy

Economic distress in rural areas and opioid exposure in cities are key indicators of overdose deaths

Greg Mankiw says there should be a market for kidneys, but not for paying drug addicts to get sterilized.

Cuba’s entirely state-owned biopharmaceutical industry has been remarkably successful, and can serve as a model for other nations

From the Rust Belt to Rural America, Economic and Social Distress Helped Shape the 2016 US Presidential Election Outcome

A better set of approaches for the 21st century.

Joseph Stiglitz, Michael Spence and a global team of leading thinkers are calling for new thinking & new rules for the world economy

Once again, an out-of-control industry is threatening public health on a mammoth scale

Price gouging in the US pharmaceutical drug industry goes back more than three decades.

Greater efficiency, lower costs, and universal coverage make it the sustainable option, say some top economists